Furthermore, it can increase the production of CD8+ T lymphocytes and immune factors (IL-2, TNF-α, and IFN-γ), thereby improving T cell recognition and the killing of tumour cells [114,244]. The gene discussed is CD8A; the disease is neoplasm.